New research suggests blood biomarkers can detect Alzheimer's signs in midlife.
The study focuses on the protein pTau181 linked to early memory concerns.
Early detection offers a critical opportunity for preventative lifestyle interventions.
Researchers from the Dunedin Study are tracking participants to understand disease progression.